Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

AutoImmune reports preliminary results from phase II trials of Colloral

May 14, 1997

Tularik receives U.S. patent relating to enzyme associated with inflammation

May 14, 1997

Panax to acquire CorBec

May 13, 1997

BioSpecifics receives grant to develop collagenase injection for Dupuytren's disease

May 12, 1997

BioCryst receives milestone payment from Torii

May 7, 1997

British Biotech and SynPhar sign research collaboration

May 7, 1997

Biosource Technologies awarded NIH grant to develop melanin as an antiinflammatory compound

May 6, 1997

Biomatrix's viscosupplementation product to be distributed by Bayer

May 2, 1997

Clodronate shows comparable efficacy to indomethacin in a rat model of arthritis

May 2, 1997

Potent, selective and orally active COX-2 inhibitors from Parke-Davis

April 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.